These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3844465)

  • 61. Prognostic value of assessing contact system activation and factor V in systemic inflammatory response syndrome.
    Pixley RA; Zellis S; Bankes P; DeLa Cadena RA; Page JD; Scott CF; Kappelmayer J; Wyshock EG; Kelly JJ; Colman RW
    Crit Care Med; 1995 Jan; 23(1):41-51. PubMed ID: 7528118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Initiation of the intrinsic coagulation and fibrinolytic pathways of man: the role of surfaces, hageman factor, prekallikrein, high molecular weight kininogen, and factor XI.
    Kaplan AP
    Prog Hemost Thromb; 1978; 4():127-75. PubMed ID: 362477
    [No Abstract]   [Full Text] [Related]  

  • 63. A study of hemostasis in ischemic cerebrovascular disease: IV. A five year follow-up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein.
    Mettinger KL
    Thromb Res; 1982 Jul; 27(2):155-60. PubMed ID: 6814002
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amidolytic prekallikrein (PK) assay: unsuitability of Cephotest as an activator.
    Lämmle B; Lohri A; Tran TH; Czendlik C
    Thromb Haemost; 1984 Apr; 51(2):294. PubMed ID: 6564798
    [No Abstract]   [Full Text] [Related]  

  • 65. Interactions among Hageman factor (HG, Factor XII), plasma thromboplastin antecedent (PTA, Factor XI), plasma prekallikrein (PK, Fletcher factor) and high molecular weight kininogen (HMW-K, Fitzgerald factor) in blood coagulation.
    Saito H; Ratnoff OD
    Adv Exp Med Biol; 1979; 120B():61-70. PubMed ID: 517254
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Contact activation factors in plasma from women on estrogen replacement therapy after ovariohysterectomy.
    Fossum S; Hoem NO; Gjønnaess H; Briseid K
    Thromb Res; 1999 Feb; 93(4):161-70. PubMed ID: 10064271
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assay of Fletcher factor (plasma prekallikrein) using an artificial clotting reagent and a modified chromogenic assay.
    Soulier JP; Gozin D
    Thromb Haemost; 1979 Aug; 42(2):538-47. PubMed ID: 505362
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor.
    Kaplan AP; Silverberg M; Dunn JT; Miller G
    Ann N Y Acad Sci; 1981; 370():253-60. PubMed ID: 6455951
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Physiological and pathological significance of plasma prekallikrein in obstetrics].
    Soga K
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Oct; 34(10):1763-72. PubMed ID: 6924684
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.
    Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S
    J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Kallikrein-kinin system in severe experimental hypertension.
    Quadra JA; Bossolan D; Stella RC; Ribeiro AB; Kohlmann O; Ramos OL
    Adv Exp Med Biol; 1986; 198 Pt B():313-9. PubMed ID: 3643729
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Role of HMW kininogen in surface-mediated activation of Factor XII.
    Shimada T; Sugo T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Coagulation and fibrinolysis associated with contact phase in plasma with high molecular weight kininogen deficiency].
    Iijima K; Nakamura K
    Rinsho Ketsueki; 1989 Oct; 30(10):1702-7. PubMed ID: 2593236
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanism and significance of kinin formation in nephrotic syndrome.
    Nakamura K; Kazama M; Morioka M; Tahara C; Abe T
    Adv Exp Med Biol; 1986; 198 Pt B():253-62. PubMed ID: 3028075
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dissemination of contact activation in plasma by plasma kallikrein.
    Cochrane CG; Revak SD
    J Exp Med; 1980 Sep; 152(3):608-19. PubMed ID: 6902742
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Kinin activation as a predictive assay for adverse reactions to radiographic contrast medium.
    Carr DH; Walker AC
    Acta Radiol Diagn (Stockh); 1984; 25(4):337-42. PubMed ID: 6567445
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization.
    Shimada T; Kato H; Maeda H; Iwanaga S
    J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen.
    Liu CY; Scott CF; Bagdasarian A; Pierce JV; Kaplan AP; Colman RW
    J Clin Invest; 1977 Jul; 60(1):7-17. PubMed ID: 874091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.